These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 27813051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L, Lentjes E, Hermus A, Zelissen P.
    Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K, Thorsen TE, Husebye ES.
    J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
    [Abstract] [Full Text] [Related]

  • 6. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F, Barbot M, Lizzul L, Selmin E, Saller A, Albiger N, Betterle C, Boscaro M, Scaroni C.
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [Abstract] [Full Text] [Related]

  • 7. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
    Ekman B, Blomgren J, Andersson PO, Carlsson M, Arnqvist HJ.
    Horm Metab Res; 2010 Dec; 42(13):961-6. PubMed ID: 20925018
    [Abstract] [Full Text] [Related]

  • 8. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
    Ng CM, Lam TK, Au Yeung YC, Choi CH, Iu YP, Shek CC, Tiu SC.
    Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
    [Abstract] [Full Text] [Related]

  • 9. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone.
    Meulenberg PM, Ross HA, Swinkels LM, Benraad TJ.
    Clin Chim Acta; 1987 Jun 15; 165(2-3):379-85. PubMed ID: 3652459
    [Abstract] [Full Text] [Related]

  • 10. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M, Gryczyńska M, Sowińska A, Sowiński J.
    Przegl Lek; 2011 Jun 15; 68(2):96-102. PubMed ID: 21751518
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
    Gagliardi L, Nenke MA, Thynne TR, von der Borch J, Rankin WA, Henley DE, Sorbello J, Inder WJ, Torpy DJ.
    J Clin Endocrinol Metab; 2014 Nov 15; 99(11):4149-57. PubMed ID: 25127090
    [Abstract] [Full Text] [Related]

  • 13. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
    Thomson AH, Devers MC, Wallace AM, Grant D, Campbell K, Freel M, Connell JM.
    Clin Endocrinol (Oxf); 2007 Jun 15; 66(6):789-96. PubMed ID: 17437510
    [Abstract] [Full Text] [Related]

  • 14. Salivary cortisol and cortisone in the clinical setting.
    Blair J, Adaway J, Keevil B, Ross R.
    Curr Opin Endocrinol Diabetes Obes; 2017 Jun 15; 24(3):161-168. PubMed ID: 28375882
    [Abstract] [Full Text] [Related]

  • 15. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
    Restituto P, Galofré JC, Gil MJ, Mugueta C, Santos S, Monreal JI, Varo N.
    Clin Biochem; 2008 Jun 15; 41(9):688-92. PubMed ID: 18280810
    [Abstract] [Full Text] [Related]

  • 16. Salivary cortisol and cortisone responses to tetracosactrin (synacthen).
    Cornes MP, Ashby HL, Khalid Y, Buch HN, Ford C, Gama R.
    Ann Clin Biochem; 2015 Sep 15; 52(Pt 5):606-10. PubMed ID: 25724424
    [Abstract] [Full Text] [Related]

  • 17. Hypothalamic-pituitary-adrenal axis suppression - The value of salivary cortisol and cortisone in assessing hypothalamic-pituitary-adrenal recovery.
    Kalaria T, Agarwal M, Kaur S, Hughes L, Sharrod-Cole H, Chaudhari R, Gherman-Ciolac C, Chopra R, Okeke V, Ford C, Buch H, Gama R.
    Ann Clin Biochem; 2020 Nov 15; 57(6):456-460. PubMed ID: 32961064
    [Abstract] [Full Text] [Related]

  • 18. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA.
    J Clin Endocrinol Metab; 1993 Jan 15; 76(1):192-6. PubMed ID: 8380605
    [Abstract] [Full Text] [Related]

  • 19. Measurement of Salivary Cortisone to Assess the Adequacy of Hydrocortisone Replacement.
    Raff H.
    J Clin Endocrinol Metab; 2016 Apr 15; 101(4):1350-2. PubMed ID: 26990943
    [Abstract] [Full Text] [Related]

  • 20. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
    Aanderud S, Myking OL, Bassøe HH.
    Acta Endocrinol (Copenh); 1982 Aug 15; 100(4):588-94. PubMed ID: 6289586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.